Research ArticleClinical Studies

A Phase II Study of Gemcitabine at Fixed Infusion Rate of 10 mg/m2/min with or without Immunotherapy in Advanced Renal Cancer

FABLE ZUSTOVICH, GIUSEPPE CARTEI, DAVIDE PASTORELLI, ORNELLA NICOLETTO, FEDRA GOTTARDO, LUCA DE ZORZI and MASSIMO DAL BIANCO
Anticancer Research November 2007, 27 (6C) 4461-4464;

Article Information

vol. 27 no. 6C 4461-4464
PubMed 
18214061
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received July 25, 2007
  • Revision received October 12, 2007
  • Accepted October 22, 2007
  • Published online November 1, 2007.
Copyright & Usage 
Copyright© 2007 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. FABLE ZUSTOVICH1,
  2. GIUSEPPE CARTEI1,
  3. DAVIDE PASTORELLI1,
  4. ORNELLA NICOLETTO1,
  5. FEDRA GOTTARDO2,
  6. LUCA DE ZORZI2 and
  7. MASSIMO DAL BIANCO2
  1. 1Oncologia Medica 1, IOV - IRCCS, Padova
  2. 2Divisione di Urologia, ULSS 16, Padova, Italy
  1. Correspondence to: Fable Zustovich, Oncologia Medica 1, IOV-IRCCS, Via Gattamelata n.64, 35128 Padova, Italy. Tel: +39 347 9775504, Fax: +39 049 8215904, e-mail: fable.zustovich{at}ioveneto.it

Cited By...

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
A Phase II Study of Gemcitabine at Fixed Infusion Rate of 10 mg/m2/min with or without Immunotherapy in Advanced Renal Cancer
FABLE ZUSTOVICH, GIUSEPPE CARTEI, DAVIDE PASTORELLI, ORNELLA NICOLETTO, FEDRA GOTTARDO, LUCA DE ZORZI, MASSIMO DAL BIANCO
Anticancer Research Nov 2007, 27 (6C) 4461-4464;
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section